Streetbeat News

AHI

Advanced Human Imaging Limited

https://www.advancedhumanimaging.com

Industry

Software - Application

Advanced Human Imaging Limited operates as a mobile application and technology development company worldwide. It develops and patents a proprietary measurement/dimensioning technology that enables end-user to check, track, and assess body dimensions privately using a smartphone. The company offers smartphone-based human scanning technology, such as BodyScan, FaceScan, DermaScan, MKScan, and HemaScan. It serves mobile health and telehealth, life and health insurance, fitness and wellness, and consumer apparel sectors. The company was formerly known as MyFiziq Limited and changed its name to Advanced Human Imaging Limited in March 2021. Advanced Human Imaging Limited was incorporated in 2014 and is based in South Perth, Australia.

Open

N/A

Mkt cap

13M

Volume

N/A

High

1.50

P/E Ratio

-4.69

52-wk high

2.56

Low

1.50

Div yield

N/A

52-wk low

1.41

US stocks traded lower with the Nasdaq Composite falling around 50 points. Energy shares rose by 2.2% while consumer discretionary shares fell by 0.5%. Walmart reported better-than-expected Q2 earnings and raised FY24 outlook. PhenomeX, LSI Industries, and Advanced Health Intelligence saw their shares rise after positive news. Creative Realities, EMCORE Corporation, and Tremor International saw their shares drop after negative news. Oil traded up 1.6% to $80.64.

Portfolio Pulse from Lisa Levin

August 17, 2023 | 4:16 pm

Advanced Health Intelligence Ltd. (NASDAQ:AHI) stock is trading higher after the company announced it was eligible for partial reimbursement by the Australian government for overseas research and development costs. The company's submission was found eligible for reimbursements of 43.5% on approved expenditures incurred abroad. The news has led to heavy trading volume, with over 33.16 million shares traded compared to the stock's 100-day average of 2.547 million shares.

Portfolio Pulse from Erica Kollmann

August 17, 2023 | 3:14 pm

Advanced Health Intelligence has announced that it has obtained overseas R&D reimbursement under the Australian Research and Development Tax Incentive Scheme. This has led to a rise in the company's share prices.

Portfolio Pulse from Benzinga Newsdesk

August 17, 2023 | 3:13 pm

US stocks traded higher with the Dow Jones gaining over 50 points. Energy shares rose by 2% while health care shares fell by 0.2%. US initial jobless claims declined by 11,000 to 239,000. Sunlight Financial Holdings, Tivic Health Systems, and Advanced Health Intelligence saw significant gains in their shares. Creative Realities, EMCORE Corporation, and Tremor International saw a drop in their shares.

Portfolio Pulse from Lisa Levin

August 17, 2023 | 1:54 pm

During Thursday's pre-market session, several healthcare stocks experienced significant movement. Tivic Health Systems, Advanced Health, Pliant Therapeutics, Modular Medical, Infinity Pharmaceuticals, and Shuttle Pharmaceuticals saw increases, with Tivic Health Systems leading with a 47.2% increase. On the other hand, T2 Biosystems, Novo Integrated Sciences, Strata Skin Sciences, Kronos Bio, Calliditas Therapeutics, and Aclarion experienced decreases, with T2 Biosystems leading the losses with a 24.4% decrease.

Portfolio Pulse from Benzinga Insights

August 17, 2023 | 1:06 pm

Modular Medical, Inc. (MODD) shares surged 34.3% in pre-market trading after announcing a partnership with Phillips-Medisize to expand insulin delivery alternatives. Sunlight Financial Holdings Inc. (SUNL) rose 30.9% in pre-market trading. Tivic Health Systems, Inc. (TIVC) shares climbed 29.1% in pre-market trading after announcing its funded study started enrollment for its non-invasive bioelectronic device approach to vagus nerve stimulation. KULR Technology Group, Inc. (KULR) fell 42.6% in pre-market trading after reporting Q2 financial results and announcing a proposed public offering of common stock. EMCORE Corporation (EMKR) shares fell 30.2% in pre-market trading after announcing a proposed public offering.

Portfolio Pulse from Lisa Levin

August 17, 2023 | 12:15 pm

Advanced Health Intelligence Ltd (NASDAQ:AHI) has successfully obtained eligibility for a 43.5% reimbursement of approved expenditures incurred abroad for overseas R&D under the Australian Government Research and Development Tax Incentive Scheme. This follows the company's acquisitions of Vertica Health and wellteq Digital Health Inc. in 2022, which expanded its global development team across the US, Singapore, South Africa, and Netherlands.

Portfolio Pulse from Charles Gross

August 16, 2023 | 11:09 pm

Advanced Health Intelligence Ltd (NASDAQ:AHI) has signed a collaboration agreement with UAE-based IntelliGen FZ-LLC to deploy AHI's technology in the Middle East. IntelliGen will receive up to 2 million AHI shares for the delivery of a $20 million license to AHI in the region, and a revenue share on all sales across the region delivered by IntelliGen.

Portfolio Pulse from Charles Gross

August 14, 2023 | 9:03 am

During Friday's intraday session, several healthcare stocks experienced significant movements. Biodexa Pharmaceuticals, Alector, OraSure Technologies, Amneal Pharmaceuticals, Natera, and Advanced Health saw their stocks rise, with Biodexa Pharmaceuticals leading the gainers with a 44.1% increase. On the other hand, Mesoblast, Assertio Holdings, INVO Bioscience, T2 Biosystems, ResMed, and Biomerica saw their stocks fall, with Mesoblast leading the losers with a 62.2% decrease.

Portfolio Pulse from Benzinga Insights

August 04, 2023 | 5:31 pm

Advanced Health Intelligence (AHI) has announced an exclusive license deal with Changlin Network Technology, leading to a rise in AHI's share prices.

Portfolio Pulse from Benzinga Newsdesk

August 04, 2023 | 3:43 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.